NYSE:LCI - Lannett Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$9.42 +0.07 (+0.75 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$9.35
Today's Range$9.35 - $9.69
52-Week Range$3.33 - $17.58
Volume1.24 million shs
Average Volume1.76 million shs
Market Capitalization$370.08 million
P/E Ratio3.04
Dividend YieldN/A
Beta2.48
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$684.56 million
Cash Flow$4.3814 per share
Book Value$8.31 per share

Profitability

Net Income$28.69 million

Miscellaneous

Employees1,251
Market Cap$370.08 million
Next Earnings Date5/6/2019 (Estimated)
OptionableOptionable

Lannett (NYSE:LCI) Frequently Asked Questions

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings data on Wednesday, February, 6th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.68 by $0.18. The business had revenue of $193.70 million for the quarter, compared to analysts' expectations of $162.51 million. Lannett had a negative net margin of 39.44% and a positive return on equity of 22.88%. The firm's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the firm posted $1.06 earnings per share. View Lannett's Earnings History.

When is Lannett's next earnings date?

Lannett is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for Lannett.

What guidance has Lannett issued on next quarter's earnings?

Lannett updated its FY 2019 earnings guidance on Wednesday, February, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $615-635 million, compared to the consensus revenue estimate of $598.79 million.

What price target have analysts set for LCI?

5 analysts have issued 12 month price targets for Lannett's shares. Their predictions range from $8.00 to $43.00. On average, they anticipate Lannett's stock price to reach $26.1667 in the next year. This suggests a possible upside of 177.8% from the stock's current price. View Analyst Price Targets for Lannett.

What is the consensus analysts' recommendation for Lannett?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Lannett.

Has Lannett been receiving favorable news coverage?

News headlines about LCI stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Lannett earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the stock's share price in the near future.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Celgene (CELG), Gilead Sciences (GILD), Akorn (AKRX), Synergy Pharmaceuticals (SGYP), Alibaba Group (BABA), Micron Technology (MU), Ambarella (AMBA), Bank of America (BAC), Skechers USA (SKX) and Netflix (NFLX).

Who are Lannett's key executives?

Lannett's management team includes the folowing people:
  • Mr. Timothy C. Crew, CEO & Director (Age 58)
  • Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
  • Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
  • Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)

Who are Lannett's major shareholders?

Lannett's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Telemus Capital LLC (20.07%), BlackRock Inc. (12.14%), Canada Pension Plan Investment Board (2.81%), Dimensional Fund Advisors LP (2.05%), Bank of New York Mellon Corp (1.57%) and Alambic Investment Management L.P. (1.07%). Company insiders that own Lannett stock include Albert Paonessa III, Arthur P Bedrosian, David Farber, Kevin Smith, Patrick G Lepore and Timothy C Crew. View Institutional Ownership Trends for Lannett.

Which major investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Telemus Capital LLC, CLARET ASSET MANAGEMENT Corp, Northern Trust Corp, KBC Group NV, Bank of New York Mellon Corp, Jane Street Group LLC and SG Americas Securities LLC. View Insider Buying and Selling for Lannett.

Which major investors are buying Lannett stock?

LCI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Canada Pension Plan Investment Board, Alambic Investment Management L.P., Two Sigma Investments LP, Prudential Financial Inc., Two Sigma Advisers LP, Martingale Asset Management L P and Municipal Employees Retirement System of Michigan. Company insiders that have bought Lannett stock in the last two years include Albert Paonessa III, Patrick G Lepore and Timothy C Crew. View Insider Buying and Selling for Lannett.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $9.42.

How big of a company is Lannett?

Lannett has a market capitalization of $370.08 million and generates $684.56 million in revenue each year. The company earns $28.69 million in net income (profit) each year or $3.10 on an earnings per share basis. Lannett employs 1,251 workers across the globe.

What is Lannett's official website?

The official website for Lannett is http://www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.


MarketBeat Community Rating for Lannett (NYSE LCI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  408 (Vote Outperform)
Underperform Votes:  321 (Vote Underperform)
Total Votes:  729
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel